Real estate-focused private equity fund manager Gaw Capital Partners has reached a combined USD900m final close for two Asia-focused funds: The first vehicle will invest in real estate opportunities; the second vehicle will target education platforms and will partner with top-tier school operators through greenfield or brownfield developments,… Read More
Wamda, EQ2 Ventures, and Nuwa Capital led a USD2.5m pre-Series B bridge round for Dubai-based eyewear e-commerce platform eyewa. Read more… Read More
FMO and Global Ventures led a USD3.5m investment in Egypt-based digital payments platform Paymob, with follow-on from A15. Read more… Read More
Sequoia Capital India led a USD20m Series A for Singapore-based online invoice trading platform Incomlend, with participation from French shipping group CMA CGM. Read more… Read More
Hong Kong-listed Viva Biotech has agreed to acquire an 80% stake in China-based contract development manufacturing organization (CDMO) company Zhejiang Langhua Pharmaceutical for USD368m. The transaction, which is pending approval, will facilitate an exit for existing shareholders including Ninhua Group, Nuobai Investments, and Zhining Investments. Read more… Read More
Aqua Capital has invested an undisclosed amount in Brazil-based foodtech Puravida. Read more… Read More
Lightspeed India Partners has reached a USD275m final close for Lightspeed India Partners III. The vehicle will focus on early-stage, seed, and Series A investments in India. Read more… Read More
Verod Capital Management has acquired 100% of Nigeria-based pension fund administrator AXA Mansard Pensions, a subsidiary of AXA Mansard Insurance, for an undisclosed amount. The transaction is subject final approval from the National Pension Commission. Read more… Read More
Arzan VC, AlTouq Group, and Nazer Group led a USD5m pre-Series A for iKcon, a Dubai-based cloud kitchen operator active across the UAE. Read more… Read More
IMM Investment, Hana Ventures, and STIC Ventures are reportedly among a pool of investors that have invested KRW44b (approximately USD37m) in Curocell, a South Korea-based biotech focused on developing immune cell therapies for blood cancers. Atinum Investment, DS Asset Management, Seoul Investment Partners, Aju IB Investment, Ulmus Investment,… Read More
(default archive template)